Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes

Bone Marrow Transplantation

Volumn 28, Issue 8, 2001, Pages 795-798

  Slavin, S ^a   Ackerstein, A ^a   Morecki, S ^a   Gelfand, Y ^a   Cividalli, G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone marrow transplantation; Chronic myeloid leukemia; Donor lymphocyte infusion; Graft versus leukemia; Immune donor lymphocytes; Immunotherapy

Indexed keywords

ALLOANTIGEN; ALPHA INTERFERON; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYUREA; METHOTREXATE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT INTERLEUKIN 2;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; CELL ACTIVATION; CELL STIMULATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DISEASE RESISTANCE; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOTHERAPY; IN VITRO STUDY; IRRADIATION; LYMPHOCYTE; MOLECULAR BIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS, ALKYLATING; BIOLOGICAL RESPONSE MODIFIERS; BONE MARROW TRANSPLANTATION; CHILD; COMBINED MODALITY THERAPY; FEMALE; HAPLOTYPES; HUMANS; HYDROXYUREA; IMMUNOTHERAPY, ADOPTIVE; INTERFERON ALFA-2A; ISOANTIGENS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; RECURRENCE; REMISSION INDUCTION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035177838     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703223     Document Type: Article

References (13)

1. Cellular-mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man
2. Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes
3. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse post allogeneic bone marrow transplantation
4. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
5. Adoptive transfer of resistance to Pseudomonas aeruginosa infection by splenocytes and bone marrow cells from BALB/c mice immunized by Pseudomonas aeruginosa lectin preparations
6. The effect of total or partial T-lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow grafts
7. Ablation of persistent hepatitis B virus infection by allogeneic bone marrow transplantation from an HBV immune donor: A preliminary report
8. Towards amplification of graft vs leukemia (GVL) effect while minimizing graft vs host disease (GVHD)
9. Increasing anti-leukemia effects while minimizing graft vs host responses following donor immunization prior to allogeneic cell therapy for murine B cell leukemia
10. Transplantation of allogeneic bone marrow without graft vs host disease using total lymphoid irradiation
11. Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin
12. Transfer of myeloma idiotype-specific immunity from an actively immunized marrow donor
13. Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT